SWELL:
Barbara Giesser, MD, Neurologist, MS Specialist, Pacific Neuroscience Institute, Providence Saint John Health Center, Santa Monica, CA.
Gabriel Pardo, MD, director of the Oklahoma Medical Research Foundation’s Multiple Sclerosis Center of Excellence in Oklahoma City.
National Society for Multiple Sclerosis: “Compliance”.
Multiple Sclerosis Trust (UK): “When can you safely stop taking disease-modifying drugs?”
Journal of Neurology, Neurosurgery and Psychiatry, “Withdrawal from Disease-Modifying Therapy in MS After an Extended Relapse-Free Period: A Study Corresponding to the Propensity Score.”
International Journal of MS Care: “Withdrawal from Disease-Modifying Therapy in Non-Recurrent Multiple Sclerosis.
Research Institute for Patient-Centered Results: “Can some MS patients safely stop taking medication?”
Comments are closed.